Showing results (4471-4480 of 6,511) with videos related to
Sort By:
Pageof 652
Experimental Hematology|April 20, 2013
Resveratrol has anti-leukemic activity associated with decreased O-GlcNAcylated proteinsJelena Tomic, Lindsay McCaw, Youjun Li, et al.Experimental Hematology|February 19, 2013
Fetal hepatic progenitors support long-term expansion of hematopoietic stem cellsSong Chou, Johan Flygare, Harvey F LodishExperimental Hematology|September 11, 2013
GSK-3β inhibition preserves naive T cell phenotype in bone marrow reconstituted miceSylvie Shen, Guy Klamer, Ning Xu, et al.Experimental Hematology|July 19, 2014
Gambogic acid inhibits multiple myeloma mediated osteoclastogenesis through suppression of chemokine receptor CXCR4 signaling pathwaysManoj K Pandey, Vijay P Kale, Chunhua Song, et al.Experimental Hematology|May 7, 2013
Myelodysplastic syndrome: an inability to appropriately respond to damaged DNA?Ting Zhou, Paul Hasty, Christi A Walter, et al.Experimental Hematology|May 8, 2013
Mechanistic studies on the synergistic cytotoxicity of the nucleoside analogs gemcitabine and clofarabine in multiple myeloma: relevance of p53 and its clinical implicationsBenigno C Valdez, Guiyun Wang, David Murray, et al.Experimental Hematology|January 1, 1975
Effect of graft-versus-host reaction on the immune response to alloantigens and growth of a syngeneic tumorM ZaleskiExperimental Hematology|October 1, 1986
Monoclonal antibodies to HLA-DP, DQ, and DR determinants: functional effects on the activation and proliferation of normal and EBV-transformed B cellsD R Howard, A C Eaves, F TakeiExperimental Hematology|December 1, 1986
Resistance of the stromal cell in murine long-term bone marrow cultures to damage by ionizing radiationK S Zuckerman, C W Prince, R K Rhodes, et al.Experimental Hematology|December 7, 2013
Activation of p53 by the MDM2 inhibitor RG7112 impairs thrombopoiesisCamelia Iancu-Rubin, Goar Mosoyan, Kelli Glenn, et al.Pageof 652